Your session is about to expire
← Back to Search
NAFLD for Healthy Subjects (AGEDDX Trial)
AGEDDX Trial Summary
This trial aims to validate biomarkers that can differentiate between different liver conditions and assess the severity of fibrosis using blood samples. The researchers will verify their testing methods using whole genome sequencing on a larger sample
AGEDDX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AGEDDX Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the research trial open to participants who have reached adulthood, typically considered as 18 years or older?
"To meet the eligibility requirements for this study, individuals must be at least 18 years old but no older than 65."
What are the eligibility criteria for participating in this clinical trial?
"To qualify for enrollment, individuals must have non-alcoholic fatty liver disease and be aged between 18 and 65 years. This research project aims to recruit a total of 400 participants."
Are there any available positions for patients in this ongoing clinical trial?
"As per the information available on clinicaltrials.gov, recruitment for this specific trial is currently closed. The trial was first listed on 5/15/2024 and last updated on 4/1/2024. Despite this trial not actively seeking participants, there are approximately 1155 other trials open to enrollment at present."
Share this study with friends
Copy Link
Messenger